PMV Pharmaceuticals (PMVP) Short Interest Ratio & Short Volume $1.00 +0.02 (+1.52%) As of 02:46 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock PMV Pharmaceuticals Short Interest DataPMV Pharmaceuticals (PMVP) has a short interest of 838,600 shares, representing 1.91% of the float (the number of shares available for trading by the public). This marks a 0.13% increase in short interest from the previous month. The short interest ratio (days to cover) is 7.3, indicating that it would take 7.3 days of the average trading volume of 130,132 shares to cover all short positions.Current Short Interest838,600 sharesPrevious Short Interest837,500 sharesChange Vs. Previous Month+0.13%Dollar Volume Sold Short$872,144.00Short Interest Ratio7.3 Days to CoverLast Record DateApril 15, 2025Outstanding Shares51,952,000 sharesFloat Size43,840,000 sharesShort Percent of Float1.91%Today's Trading Volume200,916 sharesAverage Trading Volume130,132 sharesToday's Volume Vs. Average154% Short Selling PMV Pharmaceuticals? Sign up to receive the latest short interest report for PMV Pharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartPMVP Short Interest Over TimePMVP Days to Cover Over TimePMVP Percentage of Float Shorted Over Time PMV Pharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/2025838,600 shares $872,144.00 +0.1%1.9%7.3 $1.04 3/31/2025837,500 shares $912,875.00 -5.5%1.9%6.2 $1.09 3/15/2025886,300 shares $1.12 million +1.1%2.0%6.4 $1.26 2/28/2025877,000 shares $1.20 million +1.4%2.0%5.2 $1.37 2/15/2025864,700 shares $1.20 million +0.6%2.0%5.2 $1.39 1/31/2025859,200 shares $1.22 million -37.7%2.0%4.8 $1.42 1/15/20251,380,000 shares $1.92 million +3.0%3.2%7 $1.39 12/31/20241,340,000 shares $2.02 million +2.3%3.1%6.9 $1.51 12/15/20241,310,000 shares $2.07 million +47.8%3.2%6.5 $1.58 11/30/2024886,100 shares $1.44 million +4.6%2.1%4.4 $1.62 Get the Latest News and Ratings for PMVP and Related StocksEnter your email address below to receive the latest news and analysts' ratings for PMV Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 11/15/2024846,900 shares $1.36 million 0.0%1.9%4.3 $1.61 10/31/2024847,200 shares $1.38 million -13.2%1.9%4 $1.63 10/15/2024975,900 shares $1.45 million -6.2%2.2%4.5 $1.49 9/30/20241,040,000 shares $1.55 million -1.9%2.4%4.8 $1.49 9/15/20241,060,000 shares $1.60 million +1.0%2.4%3.2 $1.51 8/31/20241,050,000 shares $1.65 million -3.7%2.4%2.9 $1.57 8/15/20241,090,000 shares $1.68 million +1.9%2.5%2.8 $1.54 7/31/20241,070,000 shares $1.78 million -7.8%2.5%2.5 $1.66 7/15/20241,160,000 shares $1.89 million -48.2%2.7%2.4 $1.63 6/30/20242,240,000 shares $3.63 million -11.5%5.1%4.2 $1.62 6/15/20242,530,000 shares $4.23 million -0.8%5.8%5.2 $1.67 5/31/20242,550,000 shares $4.64 million -0.8%5.9%4.6 $1.82 5/15/20242,570,000 shares $5.55 million -8.9%6.3%4.6 $2.16 4/30/20242,820,000 shares $5.08 million +1.4%6.9%4.7 $1.80 4/15/20242,780,000 shares $4.55 million +6.9%6.8%4.8 $1.64 3/31/20242,600,000 shares $4.42 million +15.0%6.4%4.7 $1.70 3/15/20242,260,000 shares $3.98 million +14.1%5.6%4.1 $1.76 2/29/20241,980,000 shares $3.66 million +7.6%4.9%4 $1.85 2/15/20241,840,000 shares $2.82 million +5.1%4.6%4 $1.53 1/31/20241,750,000 shares $3.08 million +12.9%4.8%3.8 $1.76 1/15/20241,550,000 shares $3.49 million -4.3%4.2%2.8 $2.25 12/31/20231,620,000 shares $5.02 million -13.4%4.4%2 $3.10 12/15/20231,870,000 shares $4.21 million +4.5%5.0%2.3 $2.25 11/30/20231,790,000 shares $4.10 million +12.6%4.9%2.2 $2.29 11/15/20231,590,000 shares $3.83 million -16.3%4.4%2 $2.41 10/31/20231,900,000 shares $2.87 million -66.8%5.5%2.4 $1.51 10/15/20235,720,000 shares $11.44 million -9.5%16.6%8.1 $2.00 9/30/20236,320,000 shares $38.80 million -0.6%18.3%14.9 $6.14 9/15/20236,360,000 shares $42.68 million +15.4%18.4%14.3 $6.71 8/31/20235,510,000 shares $39.78 million +0.6%16.3%13.9 $7.22Elon Reveals Why There Soon Won’t Be Any Money For Social Security (Ad)Elon Musk's Near-Death Experience Sparks Dire Warning for Americans After cheating death twice—once in a terrifying supercar crash with billionaire Peter Thiel, then from a deadly strain of malaria—Elon Musk emerged with a stark warning for Americans about looming financial dangers. Discover the little-known Trump IRS loophole that thousands are now using to safeguard their retirement from inflation and market turmoil—before it's too late.See why thousands of forward-thinking retirement savers are now requesting this FREE 2025 Wealth Pro 8/15/20235,480,000 shares $42.63 million -16.8%16.3%13.6 $7.78 7/31/20236,590,000 shares $43.10 million -2.2%20.7%19.2 $6.54 7/15/20236,740,000 shares $43.61 million -0.6%21.1%20.4 $6.47 6/30/20236,780,000 shares $42.44 million +2.7%21.3%19.5 $6.26 6/15/20236,600,000 shares $41.38 million +0.6%20.7%17.3 $6.27 5/31/20236,560,000 shares $35.10 million +0.5%20.6%12.2 $5.35 5/15/20236,530,000 shares $37.74 million -7.0%20.5%10.8 $5.78 4/30/20237,020,000 shares $32.36 million +1.5%22.6%11 $4.61 4/15/20236,920,000 shares $30.38 million -5.6%22.3%10.3 $4.39 3/31/20237,330,000 shares $34.96 million -12.0%23.7%10.5 $4.77 3/15/20238,330,000 shares $46.23 million -1.2%26.9%13.2 $5.55 2/28/20238,430,000 shares $60.78 million +0.5%27.2%15.7 $7.21 2/15/20238,390,000 shares $63.09 million -6.2%27.1%16.4 $7.52 1/31/20238,940,000 shares $73.31 million -4.4%28.8%16.5 $8.20 1/15/20239,350,000 shares $77.04 million -1.5%30.1%17.1 $8.24 12/30/20229,490,000 shares $82.56 million +1.9%30.6%17.6 $8.70 12/15/20229,310,000 shares $88.82 million -5.6%30.0%16.7 $9.54 11/30/20229,860,000 shares $98.40 million -5.7%31.8%16.2 $9.98 11/15/202210,460,000 shares $118.51 million -9.4%33.7%16.8 $11.33 10/31/202211,540,000 shares $142.06 million -2.1%37.6%18.3 $12.31 10/15/202211,790,000 shares $138.89 million -3.8%38.5%18.6 $11.78 9/30/202212,260,000 shares $145.89 million -6.6%40.0%18.6 $11.90 9/15/202213,130,000 shares $173.97 million +0.4%42.8%16.2 $13.25 8/31/202213,080,000 shares $182.07 million -3.0%42.6%13.8 $13.92 8/15/202213,490,000 shares $228.52 million -1.8%43.9%9.1 $16.94 7/31/202213,730,000 shares $205.26 million -4.3%45.1%8.7 $14.95 7/15/202214,340,000 shares $229.01 million +5.0%49.8%8.7 $15.97 6/30/202213,660,000 shares $194.66 million +12.8%47.4%8 $14.25 6/15/202212,110,000 shares $119.40 million -1.2%42.0%7.3 $9.86 5/31/202212,260,000 shares $144.18 million +6.4%42.6%8.5 $11.76 5/15/202211,520,000 shares $150.80 million +20.1%40.1%12.5 $13.09 4/30/20229,590,000 shares $138.96 million +23.3%32.7%10.4 $14.49 4/15/20227,780,000 shares $148.13 million -2.5%28.6%9.7 $19.04 3/31/20227,980,000 shares $166.14 million -3.3%29.4%10.1 $20.82 3/15/20228,250,000 shares $140.75 million +7.3%30.9%11.7 $17.06 2/28/20227,690,000 shares $121.81 million +11.0%28.8%11 $15.84 2/15/20226,930,000 shares $118.36 million +26.2%26.0%9.9 $17.08 1/31/20225,490,000 shares $88.17 million +13.9%20.1%9.9 $16.06 1/15/20224,820,000 shares $84.83 million +30.3%17.5%9.5 $17.60 12/31/20213,700,000 shares $85.47 million +18.2%13.4%8.6 $23.10 12/15/20213,130,000 shares $73.43 million +16.8%11.3%7.7 $23.46 11/30/20212,680,000 shares $58.29 million -0.7%9.7%6.9 $21.75 11/15/20212,700,000 shares $64.23 million -6.3%9.8%7.5 $23.79 10/29/20212,880,000 shares $68.03 million -1.7%10.5%7.7 $23.62 10/15/20212,930,000 shares $70.23 million -2.7%10.9%7.7 $23.97 9/30/20213,010,000 shares $89.70 million +30.3%11.2%7.7 $29.80 9/15/20212,310,000 shares $64.75 million -18.4%8.6%5.5 $28.03 8/31/20212,830,000 shares $85.89 million -1.4%10.6%7.2 $30.35 8/13/20212,870,000 shares $98.24 million -3.0%10.9%7.7 $34.23 7/30/20212,960,000 shares $100.67 million -3.3%11.4%8.3 $34.01Elon Reveals Why There Soon Won’t Be Any Money For Social Security (Ad)Elon Musk's Near-Death Experience Sparks Dire Warning for Americans After cheating death twice—once in a terrifying supercar crash with billionaire Peter Thiel, then from a deadly strain of malaria—Elon Musk emerged with a stark warning for Americans about looming financial dangers. Discover the little-known Trump IRS loophole that thousands are now using to safeguard their retirement from inflation and market turmoil—before it's too late.See why thousands of forward-thinking retirement savers are now requesting this FREE 2025 Wealth Pro 7/15/20213,060,000 shares $99.24 million -6.1%9.2%9.8 $32.43 6/30/20213,260,000 shares $111.36 million -1.5%9.9%11.7 $34.16 6/15/20213,310,000 shares $114.10 million -3.5%10.1%12.7 $34.47 5/28/20213,430,000 shares $117.99 million +4.6%10.5%15.1 $34.40 5/14/20213,280,000 shares $95.22 million -3.5%10.0%16 $29.03 4/30/20213,400,000 shares $115.91 million +3.0%10.6%19.3 $34.09 4/15/20213,300,000 shares $108.93 million +17.9%10.3%20.2 $33.01 3/31/20212,800,000 shares $86.86 million +54.7%8.8%18 $31.02 3/15/20211,810,000 shares $73.52 million +3.4%5.9%10.4 $40.62 2/26/20211,750,000 shares $63.33 million +7.4%5.7%11.5 $36.19 2/12/20211,630,000 shares $65.35 million +3.2%5.3%10 $40.09 1/29/20211,580,000 shares $55.28 million -11.2%5.2%9.2 $34.99 1/15/20211,780,000 shares $78.89 million No Change5.8%10.3 $44.32 PMVP Short Interest - Frequently Asked Questions What is PMV Pharmaceuticals' current short interest? Short interest is the volume of PMV Pharmaceuticals shares that have been sold short but have not yet been closed out or covered. As of April 15th, traders have sold 838,600 shares of PMVP short. 1.91% of PMV Pharmaceuticals' shares are currently sold short. Learn More on PMV Pharmaceuticals' current short interest. What is a good short interest ratio for PMV Pharmaceuticals? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. PMVP shares currently have a short interest ratio of 7.0. Learn More on PMV Pharmaceuticals's short interest ratio. Which institutional investors are shorting PMV Pharmaceuticals? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of PMV Pharmaceuticals: Group One Trading LLC, Citadel Advisors LLC, and Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for PMV Pharmaceuticals? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 1.91% of PMV Pharmaceuticals' floating shares are currently sold short. Is PMV Pharmaceuticals' short interest increasing or decreasing? PMV Pharmaceuticals saw a increase in short interest during the month of April. As of April 15th, there was short interest totaling 838,600 shares, an increase of 0.1% from the previous total of 837,500 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is PMV Pharmaceuticals' float size? PMV Pharmaceuticals currently has issued a total of 51,952,000 shares. Some of PMV Pharmaceuticals' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. PMV Pharmaceuticals currently has a public float of 43,840,000 shares. How does PMV Pharmaceuticals' short interest compare to its competitors? 1.91% of PMV Pharmaceuticals' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to PMV Pharmaceuticals: Annexon, Inc. (9.29%), Ocugen, Inc. (24.63%), iTeos Therapeutics, Inc. (6.12%), Y-mAbs Therapeutics, Inc. (8.91%), Gossamer Bio, Inc. (4.26%), DiaMedica Therapeutics Inc. (0.94%), Inventiva S.A. (1.13%), MediWound Ltd. (14.34%), Eledon Pharmaceuticals, Inc. (3.32%), Cardiff Oncology, Inc. (36.78%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Invesco QQQ ($21.71 billion), iShares 20+ Year Treasury Bond ETF ($9.48 billion), Strategy Incorporated ($8.92 billion), Charter Communications, Inc. ($3.86 billion), Apollo Global Management, Inc. ($3.86 billion), Capital One Financial Co. ($3.72 billion), Super Micro Computer, Inc. ($3.47 billion), AppLovin Co. ($2.64 billion), VanEck Semiconductor ETF ($2.46 billion), and The Kroger Co. ($2.33 billion). View all of the most shorted stocks. What does it mean to sell short PMV Pharmaceuticals stock? Short selling PMVP is an investing strategy that aims to generate trading profit from PMV Pharmaceuticals as its price is falling. PMVP shares are trading up $0.02 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against PMV Pharmaceuticals? A short squeeze for PMV Pharmaceuticals occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of PMVP, which in turn drives the price of the stock up even further. How often is PMV Pharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including PMVP, twice per month. The most recent reporting period available is April, 15 2025. More Short Interest Resources from MarketBeat Related Companies ANNX Short Interest Data OCGN Short Interest Data ITOS Short Interest Data YMAB Short Interest Data GOSS Short Interest Data DMAC Short Interest Data IVA Short Interest Data MDWD Short Interest Data ELDN Short Interest Data CRDF Short Interest Data Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:PMVP) was last updated on 5/1/2025 by MarketBeat.com Staff From Our PartnersHow to invest in Elon Musk’s Optimus before its launchElon Musk is set to completely take over the AI industry with Optimus… A breakthrough AI-powered robot that El...InvestorPlace | SponsoredElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredThis Is How Empires FallThe headlines scream tariffs and export bans — but the real damage is happening in retirement portfolios. Tim ...Investors Alley | SponsoredBlackrock’s Sending THIS Crypto Higher on PurposeWhile everyone's distracted by Bitcoin's moves, a stealth revolution is underway. One altcoin is quietly po...Crypto 101 Media | SponsoredElon Musk’s next move from the Oval Office?No one is closer to President Trump than Tesla CEO Elon Musk. He's been dubbed Trump's "first buddy." Tr...Weiss Ratings | SponsoredIs he more powerful than Trump? Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | Sponsored[Action Required] Claim Your FREE IRS Loophole GuideThis shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the ...Colonial Metals | SponsoredTrump and Buffett Are Quietly Leading America’s Gold RevivalThe “Buffett Indicator” Predicts Gold Set To Dominate for Next Decade Each time the Buffett Indicator has...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding PMV Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share PMV Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
